24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
U.S. Coronavirus Cases Near 3 Million as Hospitals in Sun Belt Fill Up With PatientsAHA News: Months After Infection, Many COVID-19 Patients Can't Shake IllnessCoronavirus Ups Anxiety, Depression in the LGBTQ CommunityMajor Medical Groups Urge Americans to Wear Face MasksBlack Patients Fare Worse After AngioplastyHow Immune System Fights COVID-19 May Be Key to Vaccine SuccessWill the COVID-19 Pandemic Leave a Mental Health Crisis in Its Wake?New U.S. Coronavirus Cases Hit Another HighMultiple Surgeries for Cleft Lip, Palate Won't Cause Major Psychological DamageHIV May Not Worsen COVID-19 OutlookU.S. Coronavirus Hospitalizations Spiking in South, WestAHA News: To Everything There Is a Season, Including Heart DiseaseAsthma, Allergies Plus Pandemic May Pose 4th of July ChallengesStroke Appears 8 Times More Likely With COVID Than With FluCOVID-19 Death Risk Twice as High in New York City as Some CountriesFireworks Are Bad News for Your LungsScientists Find Source of COVID ClotsNew U.S. Coronavirus Cases Top 50,000 as More States Slow Reopening PlansNumbers of Non-COVID-19 Deaths Up During PandemicNo Good Evidence on Accuracy of Coronavirus Antibody Tests: StudyAHA News: COVID-19 Pandemic Brings New Concerns About Excessive DrinkingMuscle Relaxants for Back Pain Are Soaring: Are They Safe?Trauma of Racism Fuels High Blood Pressure Among Black Americans: StudyCOVID-19 Blood Test Might Predict Who Will Need a VentilatorWhat's the Best DIY Face Mask Against COVID-19?Deep Brain Stimulation May Slow Parkinson's, Study FindsU.S. Could See 100,000 New Cases of COVID-19 Each Day, Fauci SaysGlobally, COVID-19 Cases May Stretch Far Beyond Official Numbers: StudyFBI: Beware of Scammers Selling Fake COVID-19 Antibody TestsAHA News: Sadness and Isolation of Pandemic Can Make Coping With Grief HarderVaping-Related Lung Injuries Still Happening -- And May Look Like COVID-19Most With Coronavirus Not Sure How They Caught It: CDCDon't Get Sick While Swimming This SummerAmid Pandemic, Too Many Americans Are Hesitating to Call 911Mask Up! Don't Let Down Your Guard Against COVID-19Wildfire Smoke Causes Rapid Damage to Your Health: StudyCOVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker SaysIntestinal Illness Spurs Recall of Bagged Salads Sold at Walmart, AldiCOVID Threatens the 3 out of 4 Americans Who Can't Work From HomeHispanic Americans Being Hit Hard By COVID-19Global Coronavirus Cases Pass 10 Million as U.S. Struggles With Surge in InfectionsStarted Early, Drug Combo Eases Fatigue of Rheumatoid Arthritis: StudyIs 'Pooled' Coronavirus Testing the Next Step for America?U.S. Coronavirus Task Force Warns of Rising Case Numbers, Especially Among YoungWho's at Highest Risk From COVID-19? CDC Updates Its ListStroke, Confusion: COVID-19 Often Impacts the Brain, Study ShowsPromising Results Mean Coronavirus Vaccine Trial Could Start by AugustWhen Can Sports Fans Safely Fill Stadiums Again?Coronavirus Baby Boom? Survey Says Maybe NotCOVID-19 Typically Mild for Babies: Study
Questions and AnswersLinks
Related Topics

Diabetes

Vaccine Might Guard Against Bacteria That Cause Diarrhea in Kids

HealthDay News
by -- Robert Preidt
Updated: Jun 24th 2020

new article illustration

WEDNESDAY, June 24, 2020 (HealthDay News) -- An experimental vaccine helps protect monkeys against bacteria that cause diarrhea in millions of children worldwide, researchers report.

Bacterial gastroenteritis -- a digestive problem associated with malnutrition among millions of children younger than age 5 each year in developing nations -- can be caused by Campylobacter bacteria. Repeated infections can stunt growth and impair brain development.

Developing an effective Campylobacter vaccine could help improve the health of people who are regularly exposed to the bacteria due to poor sanitation, according to the researchers.

The experimental vaccine uses bacteria that have been inactivated by a hydrogen peroxide-based approach called HydroVax technology.

For the study, the researchers tested it on several strains of Campylobacter in rhesus monkeys and found that it was 83% effective in preventing Campylobacter-associated diarrhea, according to the report published June 24 in the journal Science Advances.

"We're hoping to move forward into clinical trials because this is a huge problem around the world," said study co-senior author Mark Slifka, a professor at Oregon Health & Science University (OHSU), in Portland.

"Campylobacter has been associated with infant growth stunting. Targeting a disease like this can help a lot of people -- including kids in developing countries -- grow stronger by reducing the damage caused by these bacteria," Slifka said in a university news release.

There were no harmful side effects in the monkeys or in mice that received the vaccine, the study authors noted.

"We are happy with the safety of the vaccine so far, but in the end the vaccine will need to be studied in humans in the form of Phase 1 clinical trials in order to directly answer this important question," Slifka said.

Study co-senior author Ian Amanna added that the problem is not limited to developing countries.

"Along with the exciting opportunity to help children in developing countries, many people don't realize how much of a problem Campylobacter is here in the U.S.," said Amanna, vice president for research at Najit Technologies, an OHSU spinoff.

"Studies have shown that these bacteria are responsible for up to $5.6 billion in economic costs annually in America," Amanna said.

More information

The U.S. Centers for Disease Control and Prevention has more on Campylobacter.